(WASHINGTON, November 30, 2017) - The American Society of Hematology (ASH) today announced the recipients of its 2018 Scholar Awards. One of ASH's most prestigious award programs, the ASH Scholar Awards financially support fellows and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.
Each Scholar Award provides $100,000 for fellows and $150,000 for junior faculty over a two- to three-year period. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH recognizes this year's corporate supporters, AbbVie, Inc., Amgen, Inc., Gilead Sciences, Incyte Corporation, Janssen Biotech, Inc., Pharmacyclics LLC, Novartis Oncology, Pfizer, Inc., and Takeda Oncology.
"This award not only provides financial support, but also validates the importance of the research focus of hematologists who are establishing their careers as independent investigators," said ASH President Kenneth C. Anderson, MD, of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute in Boston. "We are proud to be supporting the next generation of scholars in hematology as they will play a critical role in moving the field forward."
The 2018 Scholar Awards recipients are:
Basic Research Fellows
Laura Barreyro, PhD Cincinnati Children's Hospital Medical Center Cincinnati, OH
Tomasz Brzoska, PhD University of Pittsburgh Pittsburgh, PA
David Gibb, MD, PhD Yale School of Medicine New Haven, CT
Zhaohui Gu, PhD St. Jude Children's Research Hospital Memphis, TN
Zachary Hunter, PhD Harvard Medical School Boston, MA
Moonjung Jung, MD The Rockefeller University New York, NY
Stanley Lee, PhD Memorial Sloan-Kettering Cancer Center New York, NY
Nikoleta Psatha, PhD University of Washington, School of Medicine Seattle, WA
Lindsay Rein, MD Duke University Medical Center Durham, NC
Alejo Rodriguez-Fraticelli, PhD Boston Children's Hospital Boston, MA
Srividya Swaminathan, PhD Stanford University Stanford, CA
Carlos Villa, MD, PhD University of Pennsylvania Philadelphia, PA
Kira Young, PhD The Jackson Laboratory Bar Harbor, ME
Xiaotian Zhang, PhD Van Andel Institute Grand Rapids, MI
Clinical Research Fellows
Mark Geyer, MD Memorial Sloan-Kettering Cancer Center New York, NY
Aaron Goldberg, MD, PhD Memorial Sloan-Kettering Cancer Center New York, NY
Lydia Pecker, MD Johns Hopkins University Baltimore, MD
Basic Junior Faculty
Lapo Alinari, MD, PhD The Ohio State University Columbus, OH
Jeffrey Bednarski, MD, PhD Washington University in St. Louis St. Louis, MO
Chun-Wei Chen, PhD Beckman Research Institute of the City of Hope Duarte, CA
Brandon Hadland, MD, PhD Fred Hutchinson Cancer Research Center/Seattle Children's Hospital Seattle, WA
Alisa Lee Sherick, MD University of Colorado, Anschutz Medical Campus Aurora, CO
Megan McNerney, MD, PhD The University of Chicago Chicago, IL
Faiyaz Notta, PhD University Health Network Toronto, Canada
Robert Signer, PhD University of California, San Diego La Jolla, CA
David Sykes, MD, PhD Massachusetts General Hospital Boston, MA
Nan Zhu, PhD BloodCenter of Wisconsin, Inc. Milwaukee, WI
Clinical Junior Faculty
Hema Dave, MD Children's National Health System Washington, DC
Jeremie Estepp, MD St. Jude Children's Research Hospital Memphis, TN
Jae Park, MD Memorial Sloan-Kettering Cancer Center New York, NY
Sara Sadreameli, MD Johns Hopkins University Baltimore, MD
Joanne Levy, MD, Memorial Award for Outstanding Achievement
Dan Landau, MD, PhD, of Weill Cornell Medical College in New York, will receive the 2017 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award is made possible by the family of past ASH Scholar Award recipient and distinguished Society member Joanne Levy, MD, who passed away in 2004. It is presented to the current ASH Scholar with the highest-scoring abstract for the ASH Annual Meeting, as determined by the appointed abstract reviewers.
Dr. Landau earned his medical degree from Tel Aviv University and his doctorate degree from the Paris Diderot University. He is currently an assistant professor of medicine, physiology, and biophysics at the Weill Cornell Medical College, as well as a Core Member of the New York Genome Center. He is being honored for his oral abstract (Publication #559), "Single-Cell Methylome and Transcriptome High-Resolution Maps Define the Effects of Epigenetic Modifiers on the Landscape of Hematopoietic Differentiation."
###
About the American Society of Hematology
The American Society of Hematology is the world's largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances, an online, peer-reviewed open-access journal.
About the ASH Foundation:
The ASH Foundation is dedicated to moving hematology forward through support of research, career development, and quality care and education programs. The ASH Foundation is supported through funding, resources, and leadership provided by ASH, the premier organization for physicians and scientists studying and treating blood disorders, and provides a mechanism for ASH members to give in support of critical programs. Personal donations to the ASH Foundation allow the Society to do more for hematology through the expansion or enhancement of existing programs.